Skip to main content

Day: January 28, 2022

Serstech Expands Distribution Network through ADS

Serstech has added ADS, one of the world’s top providers of military equipment, to its distribution network. ADS supports and delivers to more than 3500 customers every year, with a primary focus on the US defense and security markets, with customers in both civilian and military agencies.  A significant number of ADS’s sales professionals have a background in civilian and military agencies.  “ADS is a successful supplier of products in our category to the US government and by working with ADS, our brand and products become more visible and more accessible to the large buyers in USA. ADS has well-established connections with all relevant government civilian and military agencies, which makes this addition to our network an important and large step forward in our US sales strategy”, says Serstech CEO Stefan Sandor. For further information,...

Continue reading

DFDS: INVITATION TO CONFERENCE CALL FOR DFDS´ REPORT FOR Q4 2021

INVESTOR NEWS No. 2 – 28 January DFDS expects to publish the report for Q4 2021 on 8 February 2022 at around 08:00 CET. Torben Carlsen, CEO, and Karina Deacon, CFO, will present the report on a live conference call. The presentation in English will be followed by a Q&A session. Investors, analysts and other interested parties are invited to take part. Date:                8 February 2022 Time:               10:00 CET Telephone        DK +45 35445577                      UK +44 33 33000804                      US +1 631 913 1422 Other international numbers: https://events-ftp.arkadin.com/ev/docs/NE_W2_TF_Events_International_Access_List.pdf Access code: 69658763# If you wish to take part in the audio conference, please dial up at least five minutes before the conference begins. It will start on time, and participants...

Continue reading

DFDS: INVITATION TO CONFERENCE CALL FOR DFDS´ REPORT FOR Q4 2021

INVESTOR NEWS No. 2 – 28 January 2022 DFDS expects to publish the report for Q4 2021 on 8 February 2022 at around 08:00 CET. Torben Carlsen, CEO, and Karina Deacon, CFO, will present the report on a live conference call. The presentation in English will be followed by a Q&A session. Investors, analysts and other interested parties are invited to take part. Date:               8 February 2022 Time:              10:00 CET Telephone        DK +45 35445577                      UK +44 33 33000804                      US +1 631 913 1422 Other international numbers: https://events-ftp.arkadin.com/ev/docs/NE_W2_TF_Events_International_Access_List.pdf Access code: 69658763# If you wish to take part in the audio conference, please dial up at least five minutes before the conference begins. It will start on time, and participants...

Continue reading

Communiqué Orange – Christel Heydemann appointed Chief Executive Officer of Orange with effect from 4 April

Press release Paris, 28 January 2022   Christel Heydemann appointed Chief Executive Officer of Orange with effect from 4 April   Orange’s Board of Directors, which met on 28 January, has appointed Christel Heydemann as Chief Executive Officer of Orange with effect from 4 April 2022.   In appointing Christel Heydemann, Schneider Electric’s current Executive Vice President Europe Operations, the Board has selected a candidate who is recognized for her experience in the telecoms sector and in managing business transformations.   To safeguard the continuity of the Group’s operations and to ensure the smoothest possible transition, the Board has asked Stéphane Richard to continue as Chairman & CEO until Christel Heydemann takes up her role.   Given the Board’s decision to separate the roles of Chairman and CEO, on the new Chief Executive’s...

Continue reading

AS Tallinna Vesi held an investor conference webinar to introduce the results of the 4th quarter of 2021

Today, on 28 January 2021, AS Tallinna Vesi held an investor conference webinar where the Management Board Members Chief Executive Officer Aleksandr Timofejev and Chief Financial Officer Kristi Ojakäär introduced the performance of the 4th quarter of 2021. We thank all the participants. Webinar recording is available here and the presentation is available here. AS Tallinna Vesi´s financial results for the 4th quarter of 2021 in more detail are available here. Laura KorjusHead of CommunicationsTallinna Vesi(+372) 626 2271laura.korjus@tvesi.ee

Continue reading

Blue Biofuels, Inc. Completes $2.1 Million SEC Regulation D Securities Offering at $0.25/Share

PALM BEACH GARDENS, FL, Jan. 28, 2022 (GLOBE NEWSWIRE) — Blue Biofuels, Inc. (PINK: BIOF). – Blue Biofuels announces that it has completed a $2.1 million private placement offering of its common stock at $0.25 per share. The private offering began in January 2021 and was designated to be open for a period of one year. Accordingly, the private offering has now been terminated. Further, the Company has begun to design the 5th generation CTS system which will focus on volume production of sugars and lignin from plant-based materials for further processing into ethanol and specialty chemicals. “We understand that the market is waiting to see volume production. Our 4th generation prototype system was designed to determine the optimal parameters to achieve maximum conversion. We achieved full conversion of cellulosic material, over 99%,...

Continue reading

Fortuna regrets to report a fatality at the Lindero Mine, Argentina

VANCOUVER, British Columbia, Jan. 28, 2022 (GLOBE NEWSWIRE) — Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) regrets to report that a fatality involving a worker employed by the Company occurred yesterday at the Lindero Mine located in Salta, Argentina. The unfortunate accident occurred at the conveyor stacking system and there were no other injuries associated with the incident. The Company has notified the appropriate government and local authorities and an investigation to determine the cause of the accident is currently underway. Stacking activities at the heap leach pad have been temporarily suspended for approximately 48 hours and the operation is also taking a safety stop for a day. The Company will provide support, assistance and counseling to the worker´s family as they go through this difficult time. Jorge A. Ganoza,...

Continue reading

Konsolidator releases ERP Integration Center to enable easy connections to global cloud ERP systems

Press release no 2, 2022 Søborg 28, 2022Konsolidator releases ERP integration Center to enable easy connections to global cloud ERP systems  Today, Konsolidator launched a new product – a cloud ERP integration center to enable easy connections to global cloud ERP systems and reach a broader customer base in line with the newly released strategy “Unfolding the potential”. The ERP integration center allows users worldwide to quickly transfer financial data directly from their ERP system as Microsoft Business Central to Konsolidator, thereby improving data accessibility, quality, and productivity in the consolidation process. With the release, enterprises who use multiple ERP systems can upload all their financial data from the entire group to Konsolidator within seconds.Simplifying the consolidation process “We constantly...

Continue reading

REPORT ON MANAGERS’ RECEIPT OF RESTRICTED SHARES – VESTING – IN DAMPSKIBSSELSKABET NORDEN A/S

ANNOUNCEMENT NO. 25 – 28 JANUARY 2022 Under Article 19 of the Market Abuse Regulation Dampskibsselskabet NORDEN A/S is required to report transactions in Dampskibsselskabet NORDEN A/S’ shares by persons discharging managerial responsibilities and their close relatives. With reference to announcement no. 5/2019 the following restricted shares have vested:Name:   Jan RindboReason:   Reporting duty, CEOIssuer:   Dampskibsselskabet NORDEN A/SISIN code:   DK0010269844Instrument:   Restricted sharesTransaction:   Vesting of sharesVesting date:   28 January 2022Market:   Nasdaq CopenhagenNumber:   15,343Holding after transaction   99,937Name:   Martin BadstedReason:   Reporting duty, CFOIssuer:   Dampskibsselskabet NORDEN A/SISIN code:   DK0010269844Instrument:   Restricted sharesTransaction:   Vesting...

Continue reading

Oxford Biomedica broadens leading viral vector offerings by incorporating Homology Medicines’ established AAV capabilities into a newly formed AAV Manufacturing and Innovation Business in the U.S. with Homology Medicines as 20% owner

Oxford Biomedica and Homology Medicines to establish Oxford Biomedica Solutions LLC, a new U.S.-based AAV Manufacturing and Innovation Business  Homology Medicines to receive $130 million from Oxford Biomedica to continue to advance its three clinical programs and genetic medicines platform Oxford Biomedica to invest $50 million to fund the growth of Oxford Biomedica Solutions LLC and will own 80%, with Homology Medicines to own 20%; Homology Medicines to secure preferred key customer status Dr. Roch Doliveux to become Interim CEO of Oxford Biomedica and John Dawson to retire as CEO and remain a Board Director of Oxford Biomedica Oxford Biomedica and Homology Medicines to host webcasts today to discuss the announcement OXFORD, United Kingdom and BEDFORD, Mass., Jan. 28, 2022 (GLOBE NEWSWIRE) — Oxford Biomedica plc (LSE:OXB) (“Oxford...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.